Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
Stegelmann F, Wille K, Marchi H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R, Döhner K, et al. (2021)
Leukemia 35: 3635.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stegelmann, Frank;
Wille, Kai;
Marchi, HannahUniBi 
;
Fuchs, ChristianeUniBi ;
Schauer, Stefanie;
Sadjadian, Parvis;
Becker, Tatjana;
Kolatzki, Vera;
Döhner, Hartmut;
Stadler, Rudolf;
Döhner, Konstanze;
Griesshammer, Martin
Alle
;
Fuchs, ChristianeUniBi ;
Schauer, Stefanie;
Sadjadian, Parvis;
Becker, Tatjana;
Kolatzki, Vera;
Döhner, Hartmut;
Stadler, Rudolf;
Döhner, Konstanze;
Griesshammer, Martin
Alle
Erscheinungsjahr
2021
Zeitschriftentitel
Leukemia
Band
35
Seite(n)
3635
Urheberrecht / Lizenzen
ISSN
0887-6924
eISSN
1476-5551
Page URI
https://pub.uni-bielefeld.de/record/2959082
Zitieren
Stegelmann F, Wille K, Marchi H, et al. Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 2021;35:3635.
Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., et al. (2021). Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, 3635. https://doi.org/10.1038/s41375-021-01366-3
Stegelmann, Frank, Wille, Kai, Marchi, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, et al. 2021. “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35: 3635.
Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., et al. (2021). Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia 35, 3635.
Stegelmann, F., et al., 2021. Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, p 3635.
F. Stegelmann, et al., “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”, Leukemia, vol. 35, 2021, pp. 3635.
Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., Döhner, K., Griesshammer, M.: Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 35, 3635 (2021).
Stegelmann, Frank, Wille, Kai, Marchi, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, and Griesshammer, Martin. “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35 (2021): 3635.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 34785798
PubMed | Europe PMC
Suchen in
Google Scholar